Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure

FRIDAY, June 9, 2023 -- A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue of eClinicalMedicine. Deena P. Harji, M.B.B.S.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news